Literature DB >> 16081948

Biochemical differentiation and comparison of Desulfovibrio species and other phenotypically similar genera.

Yumi A Warren1, Diane M Citron, C Vreni Merriam, Ellie J C Goldstein.   

Abstract

Seventeen human clinical isolates representing four species of Desulfovibrio were characterized using 16S rRNA gene sequences and tests for catalase, indole, nitrate, bile, urease, formate-fumarate stimulation, desulfoviridin, motility, and hydrogen sulfide production, plus susceptibility to antimicrobial agents. Eighty additional strains representing 10 phenotypically similar genera (Bilophila, Selenomonas, Capnocytophaga, Campylobacter, Bacteroides, Sutterella, Anaerobiospirillum, Dialister, Veillonella, and Mobiluncus) were included for comparison. All Desulfovibrio species produced H2S and were desulfoviridin positive, and all Desulfovibrio species except D. piger were motile. The four Desulfovibrio species could be distinguished from each other using tests for catalase, indole, nitrate, urease, and growth on bile, with the following results (positive [+], negative [-], growth [G], and no growth [NG]): for D. piger, -, -, -, -, and G, respectively; for D. fairfieldensis, +, -, +, -, and G, respectively; for D. desulfuricans, -, -, +, +, and NG, respectively; and for D. vulgaris, -, +, -, -, and G, respectively. Resistance to the 10-microg colistin disk separated the Desulfovibrio species from most of the other genera, which were usually susceptible. These simple tests were useful for characterizing the Desulfovibrio species and differentiating them from other phenotypically similar genera.

Entities:  

Mesh:

Year:  2005        PMID: 16081948      PMCID: PMC1233901          DOI: 10.1128/JCM.43.8.4041-4045.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Bacteremia caused by a strain of Desulfovibrio related to the provisionally named Desulfovibrio fairfieldensis.

Authors:  J Loubinoux; F Mory; I A Pereira; A E Le Faou
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Presence of cytochrome c in Desulfomonas pigra.

Authors:  J F Sperry; T D Wilkins
Journal:  J Bacteriol       Date:  1977-01       Impact factor: 3.490

3.  Natural relationships among sulfate-reducing eubacteria.

Authors:  R Devereux; M Delaney; F Widdel; D A Stahl
Journal:  J Bacteriol       Date:  1989-12       Impact factor: 3.490

4.  Screening of sulfate-reducing bacteria in colonoscopy samples from healthy and colitic human gut mucosa.

Authors: 
Journal:  FEMS Microbiol Ecol       Date:  2000-12-01       Impact factor: 4.194

5.  Isolation of sulfate-reducing bacteria from human thoracoabdominal pus.

Authors:  Julien Loubinoux; Benoit Jaulhac; Yves Piemont; Henri Monteil; Alain E Le Faou
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

6.  Third human isolate of a Desulfovibrio sp. identical to the provisionally named Desulfovibrio fairfieldensis.

Authors:  B La Scola; D Raoult
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

7.  Probable new species of Desulfovibrio isolated from a pyogenic liver abscess.

Authors:  W Tee; M Dyall-Smith; W Woods; D Eisen
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

8.  Intraspecies variability of Desulfovibrio desulfuricans strains determined by the genetic profiles.

Authors:  Zofia Dzierzewicz; Joanna Szczerba; Ludmila Weglarz; Longina Swiatkowska; Dorota Jasinska; Tadeusz Wilczok
Journal:  FEMS Microbiol Lett       Date:  2003-02-14       Impact factor: 2.742

9.  Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction.

Authors:  A Fite; G T Macfarlane; J H Cummings; M J Hopkins; S C Kong; E Furrie; S Macfarlane
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

Review 10.  Desulfovibrio desulfuricans bacteremia and review of human Desulfovibrio infections.

Authors:  Ellie J C Goldstein; Diane M Citron; Victoria A Peraino; Sally A Cross
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

View more
  26 in total

1.  Desulfovibrio desulfuricans bacteremia in an immunocompromised host with a liver graft and ulcerative colitis.

Authors:  Isabel Verstreken; Wim Laleman; Georges Wauters; Jan Verhaegen
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Polymicrobial bloodstream infection with Eggerthella lenta and Desulfovibrio desulfuricans.

Authors:  Karin Liderot; Martin Larsson; Stina Boräng; Volkan Ozenci
Journal:  J Clin Microbiol       Date:  2010-08-18       Impact factor: 5.948

3.  Desulfovibrio legallii prosthetic shoulder joint infection and review of antimicrobial susceptibility and clinical characteristics of Desulfovibrio infections.

Authors:  Shawn Vasoo; Erin L Mason; Daniel R Gustafson; Scott A Cunningham; Nicolynn C Cole; Emily A Vetter; Scott P Steinmann; Walter R Wilson; Robin Patel; Elie F Berbari; Nancy K Henry
Journal:  J Clin Microbiol       Date:  2014-05-21       Impact factor: 5.948

Review 4.  Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health.

Authors:  Connie W Y Ha; Yan Y Lam; Andrew J Holmes
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

5.  Synergistes group organisms of human origin.

Authors:  Hans-Peter Horz; Diane M Citron; Yumi A Warren; Ellie J C Goldstein; Georg Conrads
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

6.  Desulfovibrio legallis sp. nov.: a moderately halophilic, sulfate-reducing bacterium isolated from a wastewater digestor in Tunisia.

Authors:  Olfa Ben Dhia Thabet; Terres Wafa; Khelifi Eltaief; Jean-Luc Cayol; Moktar Hamdi; Guy Fauque; Marie-Laure Fardeau
Journal:  Curr Microbiol       Date:  2010-09-03       Impact factor: 2.188

7.  Susceptibilities of 23 Desulfovibrio isolates from humans.

Authors:  Ken-ichi Nakao; Kaori Tanaka; Suguru Ichiishi; Hiroshige Mikamo; Toshiyuki Shibata; Kunitomo Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

8.  Shifts in the Fecal Microbiota Associated with Adenomatous Polyps.

Authors:  Vanessa L Hale; Jun Chen; Stephen Johnson; Sean C Harrington; Tracy C Yab; Thomas C Smyrk; Heidi Nelson; Lisa A Boardman; Brooke R Druliner; Theodore R Levin; Douglas K Rex; Dennis J Ahnen; Peter Lance; David A Ahlquist; Nicholas Chia
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-09-26       Impact factor: 4.254

Review 9.  Desulfovibrio fairfieldensis bacteremia associated with choledocholithiasis and endoscopic retrograde cholangiopancreatography.

Authors:  Jason D Pimentel; Raymond C Chan
Journal:  J Clin Microbiol       Date:  2007-06-13       Impact factor: 5.948

10.  Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer.

Authors:  Justin Chau; Meeta Yadav; Ben Liu; Muhammad Furqan; Qun Dai; Shailesh Shahi; Arnav Gupta; Keri Nace Mercer; Evan Eastman; Taher Abu Hejleh; Carlos Chan; George J Weiner; Catherine Cherwin; Sonny T M Lee; Cuncong Zhong; Ashutosh Mangalam; Jun Zhang
Journal:  BMC Cancer       Date:  2021-07-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.